CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Caplin Point Laboratories Ltd.

NSE: CAPLIPOINT | BSE: 524742 | ISIN: INE475E01026 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

2343.0000 21.50 (0.93%)

NSE Sep 19, 2025 15:31 PM

46.53% Gain from 52W Low

Volume: 84,437

Caplin Point Laboratories Ltd.

16 Apr 2024

2343.00

0.93%

Company Update

CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Please find the attached Press Release on USFDA approval for Ofloxacin Ophthalmic Solution ANDA.

More from Caplin Point Laboratories Ltd.

Recommended

Five Interesting Stocks Today - September 19, 2025

The Baseline | 19 Sep 2025, 04:31PM

Market closes lower, JSW Energy arm to acquire Tidong Power

Trendlyne Marketwatch | 19 Sep 2025, 03:58PM

Caplin Point Laboratories maintains export momentum, expands ambitions to new markets